{
    "nctId": "NCT01339780",
    "briefTitle": "Imaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine Techniques",
    "officialTitle": "N/A",
    "overallStatus": "COMPLETED",
    "conditions": "Bone Metastases",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 53,
    "primaryOutcomeMeasure": "Number of participants with bone metastases",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age: 40 to 80 years\n* Language spoken: Finnish or Swedish\n* Performance status: Karnofsky score 70 or better or WHO performance status 2 or better\n* Diagnosis: Histologically confirmed prostate or breast cancer\n* Mental status: Patients must be able to understand the meaning of the study\n* Informed consent: The patient must sign the appropriate Ethics Committee (EC) approved informed consent documents in the presence of the designated staff\n* strong suspicion of first bone metastatic disease (already diagnosed metastases in other organs, elevated tumor markers, destruction of bone in plain x-ray or otherwise specified reasons\n* adjuvant chemo- or endocrine therapy is allowed\n\nExclusion Criteria:\n\n* Ongoing treatment for metastatic disease\n* Contraindications for MRI (cardiac pacemaker, intracranial clips etc.)\n* Infections: Patient must not have an uncontrolled serious infection\n* Claustrophobia",
    "sex": "ALL",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}